Latest Research Collaboration News

Pure Resources has launched a cutting-edge research collaboration with Rice University to develop carbon nanotube fibre thermal management systems, leveraging graphite from its Garnet Hills Project. The initiative is backed by a $3 million equity raise to fund exploration and downstream material innovation.

Heavy Rare Earths Limited has confirmed the presence of valuable rare earth minerals Monazite and Xenotime at its Radium Hill Project, signalling new potential beyond historic uranium mining.

BPH Global is expanding its seaweed biomass research to develop renewable biofuels like biohydrogen and biocrude, aiming to carve out a sustainable alternative to fossil fuels in energy and transport sectors.

Neurotech International reports a dramatic reduction in half-year losses alongside significant clinical and regulatory progress for its lead cannabinoid therapy NTI164. The company also strengthens its cash position through a $4 million placement and a $4.7 million R&D tax refund.

Prescient Therapeutics reported a 62.8% increase in half-year losses to nearly $4 million, driven by intensified clinical development of its PTX-100 cancer therapy. The company bolstered its balance sheet with a $9.85 million capital raise while securing key regulatory milestones in Europe and the US.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Noxopharm Limited has secured a major scientific milestone with the publication of its Sofra™ platform research in Nature Immunology, highlighting a novel anti-inflammatory mechanism with broad therapeutic potential.

Critical Resources Limited has secured a strategic position within the US Centre for Solid-State Electric Power Storage, accelerating its evaluation and development of safer, higher-performance solid-state lithium-ion batteries.

HITIQ has made significant strides in expanding its concussion management technology, PROTEQT©, into North America and Australian retail, backed by strong research partnerships and a successful capital raise.

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

Battery Age Minerals has completed maiden drilling programs in Austria and Argentina, secured full ownership of its Canadian lithium project, and raised A$5.5 million to fuel its 2026 exploration ambitions.

Australasian Metals Limited has reported promising exploration results at its May Queen gold and bauxite projects, alongside strategic reviews of lithium assets and a solid cash position heading into 2026.